These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 17413320

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice.
    Linker RA, Sendtner M, Gold R.
    J Neurol Sci; 2005 Jun 15; 233(1-2):167-72. PubMed ID: 15949503
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts.
    de Waegh SM, Brady ST.
    J Neurosci Res; 1991 Sep 15; 30(1):201-12. PubMed ID: 1795404
    [Abstract] [Full Text] [Related]

  • 28. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 15; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 29. [Ubiquitin immunoreactivity in the central nervous system of gracile axonal dystrophy (GAD) mouse].
    Wu J, Ichihara N, Chui DH, Yamazaki K, Kikuchi T.
    No To Shinkei; 1995 Sep 15; 47(9):881-5. PubMed ID: 7546937
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurofilament light as an immune target for pathogenic antibodies.
    Puentes F, van der Star BJ, Boomkamp SD, Kipp M, Boon L, Bosca I, Raffel J, Gnanapavan S, van der Valk P, Stephenson J, Barnett SC, Baker D, Amor S.
    Immunology; 2017 Dec 15; 152(4):580-588. PubMed ID: 28718500
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Axonal changes in chronic demyelinated cervical spinal cord plaques.
    Lovas G, Szilágyi N, Majtényi K, Palkovits M, Komoly S.
    Brain; 2000 Feb 15; 123 ( Pt 2)():308-17. PubMed ID: 10648438
    [Abstract] [Full Text] [Related]

  • 38. Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis.
    Wang P, Jiang LL, Wang C, Zhu Z, Lai C.
    Neurol India; 2020 Feb 15; 68(2):364-367. PubMed ID: 32189712
    [Abstract] [Full Text] [Related]

  • 39. Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration.
    Chen Q, Peto CA, Shelton GD, Mizisin A, Sawchenko PE, Schubert D.
    J Neurosci; 2009 Jan 07; 29(1):118-30. PubMed ID: 19129390
    [Abstract] [Full Text] [Related]

  • 40. Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
    Ehling R, Lutterotti A, Wanschitz J, Khalil M, Gneiss C, Deisenhammer F, Reindl M, Berger T.
    Mult Scler; 2004 Dec 07; 10(6):601-6. PubMed ID: 15584481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.